[ORGANIZATION]
BNT113
Featured in 1 tracked story · first seen
Situations
BioNTech BNT113 clinical trial results
2 clusters · 6 sources · last updated
Latest: BioNTech BNT113 fails first clinical endpoint in head and neck cancer trial
BioNTech reported that its experimental mRNA cancer immunotherapy, BNT113, failed to meet the primary endpoint in a combined Phase 2/3 clinical trial known as AHEAD-MERIT. The study evaluated the combination of BNT113 an